Clinical trial
Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast…
NCT00424164 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00424164 |
|---|---|
| Title | Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer |
| Official title | Pharmacokinetics Study of Combined Treatment Lapatinib and Tamoxifen in Advanced/Metastatic Breast Cancer |
| Acronym | LAPATAM |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Other |
| Interventions | lapatinib ditosylate, tamoxifen citrate, pharmacological study |
| Enrollment | 20 |
| Start date | Nov 1, 2006 |
| Primary completion | Jun 1, 2009 |
| Completion | May 28, 2010 |
| First posted | Jan 18, 2007 |
| Last update posted | Mar 8, 2024 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: